Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04278144 |
|---|---|
| Brief Title: | A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors |
| First Submitted : | February 12, 2020 |
| First Submitted that Met QC Criteria : | February 18, 2020 |
| First Posted : | February 20, 2020 |
| Last Update Submitted that Met QC Criteria : | February 28, 2024 |
| Last Update Posted : | February 29, 2024 |